Why CNS Pharmaceuticals (CNSP) Stock Is Up 86%
Why CNS Pharmaceuticals (CNSP) Stock Is Up 86%
Per a Wednesday SEC filing, CNS Pharmaceuticals says there's no guarantee of an additional extension being granted.
CNS Pharmaceuticals Inc (NASDAQ:CNSP) shares are trading higher by 86% to 29 cents Wednesday morning. The company received a notice from Nasdaq on September 12, stating that its stock had failed to meet the minimum bid price of $1.00 per share for 30 consecutive business days, which is required for continued listing on the Nasdaq Capital Market.
周三上午，CNS制药公司（纳斯达克股票代码：CNSP）股价上涨86％，至29美分。该公司于9月12日收到纳斯达克的通知，称其股票连续30个工作日未能达到每股1.00美元的最低出价，这是继续在纳斯达克资本市场上市所必需的。
Typically, companies have 180 days to regain compliance. However, CNS is ineligible for this extension due to previous reverse stock splits totaling a 250-to-1 ratio over the past two years.
通常，公司有 180 天的时间来恢复合规性。但是，CNS没有资格延期，因为在过去两年中，此前的反向股票拆分总比率为250比1。
As a result, the company has requested a hearing, scheduled for November 5, which temporarily delays any delisting actions.
因此，该公司要求举行定于11月5日举行的听证会，该听证会暂时推迟了任何退市行动。
Per a Wednesday SEC filing, CNS Pharmaceuticals says there's no guarantee of an additional extension being granted.
根据美国证券交易委员会周三的一份文件，CNS Pharmicals表示，无法保证会获得进一步的延期。
Read Also: Tesla Stock Faces Selling Pressure Ahead Of Q3 Earnings: 4 Takeaways From The Chart
另请阅读：特斯拉股票在第三季度财报前面临抛售压力：图表中的4个要点
According to data from Benzinga Pro, CNSP has a 52-week high of $137.50 and a 52-week low of $0.09.
根据Benzinga Pro的数据，CNSP的52周高点为137.50美元，52周低点为0.09美元。
